The UMass Chan Diabetes Center of Excellence (DCOE) congratulates Doug Melton, PhD, who was awarded the Doctor Juan Abarca International Award for Medical Sciences for pioneering the process of converting stem cells into insulin-producing beta cells. Dr. Melton is the founder of Harvard’s Stem Cell and Regenerative Biology Laboratory. For over a decade, the UMass DCOE has collaborated with the Melton lab to further characterize these cells’ survival and function in our novel humanized mouse models. We share a common goal of protecting them from autoimmune attack.
Recent Posts
- CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission
- Stem cell therapy linked to lower risk of heart failure after a heart attack
- Embryo-Like ‘Blood Factories’ Could One Day Supplement Donations
- Long-Term Growth Hormone Therapy Boosts Pediatric Stem Cells
- New UCLA drug could restore heart and organ function
- Parkinson’s treatment tested at UW showing promise in first clinical trial

